Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis

NCT03576287 is registered in ClinicalTrials.gov with Tanja Todberg, MD as lead sponsor.

NCT NCT03576287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03576287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
Lead sponsor
Tanja Todberg, MD
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 1, 2017
Completion date
December 1, 2019
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prurigo nodularis